Aytu BioScience Submits Notice of Commercialization to the FDA, Allowing for Company's Distribution of its 2-10 Minute COVID-19 IgG/IgM Point-of-Care Rapid Test

Stock Information for Aytu BioPharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Aytu BioPharma Inc.

Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024
Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now
Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter
Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024
Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now
Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023
Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.